Jazan Health Cluster
Jizan, 86611, Saudi Arabia
NCT Number: NCT07654933
This study examines the short-term effects of physiotherapy on functional status, ambulation, and independence among patients admitted to the palliative care unit at Jazan Specialist Hospital. The study hypothesizes that a short-term individualized physiotherapy program will lead to measurable improvements in functional outcomes as assessed by the Barthel Index (BI), Functional Ambulation Category (FAC), and Palliative Performance Scale (PPS).
Looking for future studies?
Notify Me18 year–85 year
All sexes
Interventional
Not applicable
Jizan, 86611, Saudi Arabia
A prospective single-group pre-post quasi-experimental study was conducted in the Palliative Care Unit at Jazan Specialist Hospital, Jazan, Saudi Arabia, between August 2025 and April 2026. Sixty patients were managed during the study period; of these, 32 patients with complete paired pre- and post-intervention assessments were included in the final statistical analysis. Patients received an individualized physiotherapy program once daily for one week (7 sessions), with each session lasting approximately 45-60 minutes. The intervention included range-of-motion exercises, manual therapy, strengthening exercises, stretching, mobility training, transfer training, ambulation exercises, positioning, and chest physiotherapy. Outcome measures included the Barthel Index (BI), Functional Ambulation Category (FAC), and Palliative Performance Scale (PPS). Pre- and post-intervention data were analyzed using the Wilcoxon signed-rank test.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Individualized Physiotherapy Program Participants received an individualized physiotherapy program delivered once daily for one week (7 sessions), each lasting approximately 45-60 minutes. The program included: range-of-motion exercises, manual therapy, strengthening exercises, stretching, mobility training, transfer training, ambulation exercises, positioning, and chest physiotherapy, as clinically appropriate. The program was tailored to each patient's functional status, clinical condition, and tolerance, with modifications made according to daily clinical assessment. Outcome measures: Barthel Index (BI), Functional Ambulation Category (FAC), and Palliative Performance Scale (PPS) assessed at baseline (within 24-48 hours of recruitment) and after completion of the one-week intervention (day 7).
Time frame: [Time Frame: Timepoint 1 = Baseline (within 24-48 hours of recruitment). Timepoint 2 = Post-intervention (day 7 or at discharge).]
The BI assesses independence in activities of daily living, with higher scores indicating greater independence. Scores range from 0 to 100.
Time frame: [Time Frame: Timepoint 1 = Baseline. Timepoint 2 = Post-intervention (day 7 or at discharge).]
The FAC assesses walking ability and level of assistance required for ambulation. Scores range from 0 (non-ambulatory) to 5 (independent ambulation on all surfaces).
Time frame: [Time Frame: Timepoint 1 = Baseline. Timepoint 2 = Post-intervention (day 7 or at discharge).]
The PPS assesses overall functional status in palliative care, with higher scores indicating better functional performance. Scores range from 0 to 100 in increments of 10.
University of Jazan
Other Gov
Short-Term Effects of Physiotherapy on Functional Status, Ambulation, and Independence in Palliative Care Cancer Patients at Jazan Specialist Hospital: A Prospective Quasi Experimental Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03042156
Advanced Cancer, Immunotherapy
Toronto, Ontario, Canada
View Trial DetailsNCT04864418
Advanced Cancer
Seoul, South Korea
View Trial DetailsNCT07712237
Advanced Cancer
Taipei, Taipei City, Taiwan
View Trial DetailsNCT06722014
Advanced Cancer, Mental Disorders
Boston, Massachusetts, United States
View Trial Details